Keywords: options, g/aventis, link-up, reviewed, broker, natexis, setting
Options for a P&G/Aventis link-up reviewed by broker Natexis
Article | 26 January 2004
Setting aside rumors that US conglomerate Procter & Gamble is preparing to make a takeover bid for Franco-German drugmaker Aventis (Marketletter ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
